Endocarditis Clinical Trial
Official title:
Impact of Targeted Preoperative Dental Screening on Post-procedural Risk of Infective Endocarditis in Patients Undergoing Transcatheter Aortic Valve Implantation: a Prospective Observational Study
In Odense University Hospital preoperative dental screening (PDS) protocol for patients treated with Transcatheter Aortic Valve Implantation (TAVI) was changed from mandatory to targeted PDS to between June 2023 to october 2023. The investigators will therefore compare the risk of IE before june 2023 and after october 2023.
Infective endocarditis (IE), a condition linked with significant mortality and morbidity rates, is particularly concerning for patients with prosthetic left-sided valves. These patients face an elevated IE risk, estimated at about 1% annually in tertiary care settings, cumulatively impacting around one in every 20 patients over a decade. In line with this, both the American Heart Association (AHA) and the European Society of Cardiology (ESC) strongly advocate for the elimination of potential dental sepsis sources at least two weeks before prosthetic valve implantation, except in urgent cases. These guidelines, while not grounded in randomized trials, largely draw upon registry data detailing IE incidence among surgical aortic valve replacement (SAVR) patients. In a recent study the investigators found no difference in risk of IE when comparing mandatory preoperative dental screening (MPDS) with no preoperative dental screening (NPDS). Thus, this prospective registry-based observational before-and-after study aims to investigate the impact of different preoperative dental screening practices on the risk of IE in patients undergoing. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05547607 -
Clinical and Diagnostic Features of Endocarditis
|
||
| Completed |
NCT00750373 -
Early Surgery Versus Conventional Treatment in Infective Endocarditis
|
Phase 4 | |
| Recruiting |
NCT03690076 -
Human Cardiac Mitochondria in Acute Endocarditis and Obesity
|
||
| Terminated |
NCT01734694 -
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
|
Phase 4 | |
| Terminated |
NCT00995384 -
Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis
|
N/A | |
| Completed |
NCT04309591 -
Cytosorb Therapy in Cardiac Surgery
|
||
| Recruiting |
NCT05142891 -
Renal Tolerance of Amoxicillin and Cloxacillin Combination
|
||
| Recruiting |
NCT05703022 -
Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis.
|
N/A | |
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
| Recruiting |
NCT03892174 -
Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)
|
N/A | |
| Completed |
NCT03695861 -
Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves
|
N/A | |
| Recruiting |
NCT02759978 -
Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
|
||
| Completed |
NCT00709358 -
Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections
|
Phase 4 | |
| Terminated |
NCT03148756 -
Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
|
Phase 2 | |
| Enrolling by invitation |
NCT05156437 -
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
|
Phase 4 | |
| Recruiting |
NCT06107309 -
Suppressive Antibiotic Therapy for Endocarditis
|
||
| Completed |
NCT02251262 -
Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection
|
N/A | |
| Recruiting |
NCT03112356 -
The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials
|
Phase 4 | |
| Completed |
NCT01375257 -
Partial Oral Treatment of Endocarditis
|
Phase 4 |